Real-World Experiences With a Direct-Acting Antiviral Agent for Patients With Hepatitis C Virus Infection

CONTEXT: Traditional hepatitis C virus treatment was limited by low cure rates, side effects, and stringent monitoring requirements. Sofosbuvir, a direct-acting antiviral agent with a cure rate of 96%, was introduced in 2013. However, trials frequently excluded patients with advanced liver disease a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Perm J
Main Authors: Louie, Vincent, Latt, Nyan L, Gharibian, Derenik, Sahota, Amandeep, Yanny, Beshoy T, Mittal, Rasham, Bider-Canfield, Zoe, Cheetham, T Craig
Formato: Artigo
Idioma:Inglês
Publicado: The Permanente Journal 2017
Assuntos:
Original Research & Contributions
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378486/
https://ncbi.nlm.nih.gov/pubmed/28368787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/16-096
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares